Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.

Also called NCT04271189

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 108 participants (enrolled count) (from the registry)
Sponsor
Azienda Ospedaliero-Universitaria di Parma (from the registry)
Registry
  • NCT NCT04271189
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04271189. Randomized; no masking; primary purpose treatment. Start 2020-09-01 (actual); primary completion 2024-08-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs
Acronym
MIRACLE
Condition
Newly Diagnosed Type 2 Diabetes
Intervention (Drug)
Metformin-Sitagliptin-Empaglifozin-Pioglitazone
Intervention (Drug)
Standard of care
Lead sponsor
Azienda Ospedaliero-Universitaria di Parma (class: other)

Record details

Record id
cardio:ct-nct04271189
Content hash
ae2c4bf9a8ab47d5b79c5d3d2b591b964198cb97a86e3ee0b0257a15b2fe4d2f